Premium Reports
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

2016 Midterm Performance Review
|
2016
2015 Midterm Performance Review
|
2015
2014 Mid-Term Performance Review - Software and Professional Services
|
2014
2012 Mid-Term Performance Review - Software and Professional Services
|
2012
2011 Mid-Term Performance Review - Software and Professional Services
|
2011
2010 Mid-Term Performance Review - Software and Professional Services
|
2010
2009 Mid-Term Performance Review - Software and Professional Services
|
2009
2008 Mid-Term Performance Review - Software and Professional Services
|
2008

 End chart zoom
2013 Mid-Term Performance Review - Software and Professional Services 2013 Mid-Term Performance Review - Software and Professional Services
* A page refresh may be necessary to see the updated image

2013 Mid-Term Performance Review - Software and Professional Services

June 14, 2013

Current Time Inside Cache Tag Helper: 10/17/2021 12:48:49 AM and Model.reportId = 871

The 2013 Mid-Term Performance Review: Software & Services report profiles hundreds of software and services vendors, providing a detailed look at the performance of each company's product line. The report aggregates performance data gathered over the past 12 months. The findings represent the voice of thousands of providers sharing their candid experience with various healthcare technology and vendors. Preview the report sample above to access more information about the 2013 Mid-Term Performance Review: Software & Services report.

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.